Grufity logo
Grufity logo
INDP

INDP - Indaptus Therapeutics, Inc. Stock Price, Fair Value and News

$3.79+0.10 (+2.71%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

Price Targets

INDP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INDP Price Action

Last 7 days

74.8%

Last 30 days

130.8%

Last 90 days

87.2%

Trailing 12 Months

-59.7%

INDP RSI Chart

INDP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INDP Valuation

Market Cap

417.9M

Price/Earnings (Trailing)

-22.16

EV/EBITDA

-19.97

Price/Free Cashflow

-24.84

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

INDP Fundamentals

INDP Earnings

Earnings (TTM)

-18.9M

Earnings Growth (Yr)

43.94%

Earnings Growth (Qtr)

68.68%

INDP Profitability

Return on Equity

-1.5K%

Return on Assets

-202.55%

Free Cashflow Yield

-4.03%

INDP Investor Care

Shares Dilution (1Y)

19674.84%

Diluted EPS (TTM)

-14.12

About Indaptus Therapeutics, Inc.

INDP
Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
 CEO
 WEBSITEhttps://indaptusrx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES6

Indaptus Therapeutics, Inc. Frequently Asked Questions

INDP is the stock ticker symbol of Indaptus Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of Indaptus Therapeutics, Inc. is 417.86 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

In the past 10 years, Indaptus Therapeutics, Inc. has provided -0.548 (multiply by 100 for percentage) rate of return.